<DOC>
	<DOCNO>NCT03093103</DOCNO>
	<brief_summary>SGLT-2 inhibitor belong new class hypoglycemic drug unique property decrease blood glucose increase glucosuria . These drug inhibit sodium glucose transporter 2 ( SGLT2 ) express luminal membrane proximal tubule . SGLT-2 inhibition type 2 diabetic subject healthy volunteer shift threshold renal glucose excretion low level . This effect independent insulin . The inhibition SGLT2 decrease HbA1C , systolic blood pressure weight diabetic subject . Recently , EMPA-REG trial demonstrate decrease cardiovascular mortality renal endpoint empagliflozin treat type 2 diabetic patient establish cardio-vascular disease . Because novel hypoglycemic drug unique direct effect renal tissue metabolism , important good examine effect kidney . With study , propose explore effect empagliflozin renal tissue oxygenation . Our hypothesis SGLT-2 inhibition decrease renal cortical energy requirement consequently increase renal tissue oxygenation .</brief_summary>
	<brief_title>Empagliflozin Renal Oxygenation Healthy Volunteers</brief_title>
	<detailed_description>This study double-blind , randomize , placebo-controlled study examine acute chronic renal effect empagliflozin healthy volunteer . A total 45 healthy volunteer include study : 15 normal weight , 15 overweight ( BMI : 25-30kg/m2 ) 15 obese ( BMI &gt; 30kg/m2 ) non diabetic subject ( determined oral glucose tolerance test ) . Empagliflozin 10mg v placebo administer blinded fashion qd . The acute chronic renal response empagliflozin assess .</detailed_description>
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Normal weight ( BMI : 1924.9kg/m2 ) , overweight ( BMI:2530kg/m2 ) obesity ( BMI &gt; 30kg/m2 ) Men woman ( negative pregnancy test ) follicular phase menstrual cycle . All group balance number men woman . OGTT/HbA1C : normal prediabetes eGFR &gt; 60ml/min , albumin/creatinine ratio &lt; 3.3mg/mmol ( &lt; 30 mg/g ) Signed consent form Normal renal ultrasound Normal urine dipstick Antihypertensive therapy NSAID treatment Former bariatric surgery Age &lt; 18y &gt; 50y At risk dehydration hypotension Past history recurrent genital urinary tract infection Contraindication MR imaging ( pacemaker implant metallic device , claustrophobia ) Pregnancy Sustained systolic blood pressure &gt; 150mmHg diastolic blood pressure &gt; 95mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>empagliflozin</keyword>
	<keyword>kidney</keyword>
	<keyword>BOLD-MRI</keyword>
</DOC>